PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
+4.41%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.57B
AUM Growth
+$2.57B
(+5.3%)
Cap. Flow
+$76.6M
Cap. Flow
% of AUM
2.98%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
1,569
New
131
Increased
977
Reduced
423
Closed
37
Top Buys
| 1 |
Amgen
AMGN
|
$5M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$4.98M |
| 3 |
AGN
Allergan plc
AGN
|
$4.91M |
| 4 |
Gilead Sciences
GILD
|
$4.73M |
| 5 |
Qorvo
QRVO
|
$4.33M |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
$7.22M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$6.44M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$3.48M |
| 4 |
RFMD
RF MICRO DEVICES INC
RFMD
|
$3.03M |
| 5 |
Procter & Gamble
PG
|
$2.76M |
Sector Composition
| 1 | Healthcare | 34.98% |
| 2 | Technology | 14.31% |
| 3 | Consumer Discretionary | 7.2% |
| 4 | Communication Services | 6.5% |
| 5 | Financials | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $120M | 4.68% | 1,226,722 +48,251 | +4% | +$4.73M |
|
|
2
Amgen
AMGN
$155B
| $99.9M | 3.89% | 625,016 +31,268 | +5% | +$5M |
|
3
Biogen
BIIB
$19.4B
| $81.5M | 3.17% | 192,997 +8,350 | +5% | +$3.53M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $76M | 2.96% | 659,140 +35,581 | +6% | +$4.1M |
|
5
AbbVie
ABBV
$372B
| $72M | 2.8% | 1,229,243 +70,085 | +6% | +$4.1M |
|
6
Apple
AAPL
$3.45T
| $64.6M | 2.51% | 519,362 -5,470 | -1% | -$681K |
|
7
Intel
INTC
$107B
| $35.7M | 1.39% | 1,142,468 +8,654 | +0.8% | +$271K |
|
8
Alphabet (Google) Class C
GOOG
$2.58T
| $34.4M | 1.34% | 62,344 -806 | -1% | -$444K |
|
9
Johnson & Johnson
JNJ
$427B
| $33.9M | 1.32% | 336,698 +14,815 | +5% | +$1.49M |
|
10
Microsoft
MSFT
$3.77T
| $29.6M | 1.15% | 728,735 -15,473 | -2% | -$629K |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $28.9M | 1.12% | 166,530 +11,436 | +7% | +$1.98M |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $28M | 1.09% | 61,961 +3,106 | +5% | +$1.4M |
|
13
Pfizer
PFE
$141B
| $25.3M | 0.99% | 728,136 +18,017 | +3% | +$627K |
|
14
Exxon Mobil
XOM
$487B
| $24M | 0.93% | 282,623 -12,504 | -4% | -$1.06M |
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $23.5M | 0.91% | 199,169 +12,336 | +7% | +$1.46M |
|
16
Illumina
ILMN
$15.8B
| $21.2M | 0.83% | 114,275 +6,317 | +6% | +$1.17M |
|
17
Amazon
AMZN
$2.44T
| $21M | 0.82% | 56,526 +905 | +2% | +$337K |
|
18
Meta Platforms (Facebook)
META
$1.86T
| $20.9M | 0.81% | 254,100 +3,213 | +1% | +$264K |
|
19
Merck
MRK
$210B
| $19.7M | 0.77% | 343,553 +15,680 | +5% | +$901K |
|
20
BioMarin Pharmaceuticals
BMRN
$11.2B
| $14.6M | 0.57% | 117,289 +12,349 | +12% | +$1.54M |
|
21
Texas Instruments
TXN
$184B
| $14.3M | 0.56% | 250,370 +5,401 | +2% | +$309K |
|
|
AGN
22
DELISTED
Allergan plc
AGN
| $13.9M | 0.54% | 46,548 +16,506 | +55% | +$4.91M |
|
23
Comcast
CMCSA
$125B
| $13.8M | 0.54% | 243,948 +1,449 | +0.6% | +$81.8K |
|
24
Chevron
CVX
$324B
| $13.7M | 0.53% | 130,758 -5,201 | -4% | -$546K |
|
25
Bristol-Myers Squibb
BMY
$96B
| $12.7M | 0.49% | 197,020 +10,746 | +6% | +$693K |
|